Eupraxia Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.76

-0.12 (-1.74%)

As of Nov 5, 2:28 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +555.9% upside

Low Target $25.23

Average Target $44.34

High Target $48.95

Current Price $6.76

Current
$6.76

Target
$44.34

$25.23 $44.34 avg $48.95

Scenario Analysis

Bear Case

$25.23

273.2%

Low target

Base Case

$44.34

+555.9%

Avg target

Bull Case

$48.95

+624.1%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$13.08

-48.3% from high

52-Week Low

$7.35

+-8.0% from low

Target vs 52W High

$44.34

+239.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%